Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Carson W. Smith"'
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and, Carolyn K. Shore, Tequam L. Worku, Carson W. Smith, Jeffrey P. Kahn
Rare diseases, such as sickle cell disease and thalassemia, affect up to 30 million people in the United States and at least 300 million across the globe. Congress called on the U.S. Food and Drug Administration (FDA) to sponsor a National Academies
